-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
The importance of considering ADHD in smoking cessation clinical trials
L Cinnamon Bidwell & Adam M Leventhal
Editorial: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacological treatment of gastrointestinal stromal tumors: update from recent clinical trials
M Agulnik, K Adekola, J Wayne
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation